查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451694

2024-2032 年男性不孕症市場報告（按測試類型、治療、配銷通路、最終用戶和地區）

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2023年全球男性不孕症市場規模達40億美元。展望未來， IMARC Group預計到2032年市場規模將達到62億美元，2024-2032年複合年成長率（CAGR）為4.79%。男性不孕症的盛行率不斷上升、延遲生育的趨勢不斷上升、重大技術進步、生活方式的不斷變化、對不孕症的認知不斷提高以及輔助生殖技術的合法化是推動市場的一些主要因素。

男性不孕症是指男性因生殖系統原因而無法使女性伴侶受孕的情況。它通常歸因於精子產生、品質或交付的問題。可能導致男性不孕的因素包括精子數量低、精子形狀或活動力異常、荷爾蒙失衡、遺傳因素以及某些醫療狀況，如精索靜脈曲張（陰囊靜脈擴張）。過度飲酒、吸煙、吸毒和肥胖等生活方式因素也可能導致男性不孕。

全球男性不孕症發生率的上升是市場的重要驅動力。生活方式的改變、環境污染物和壓力相關因素加劇了這種日益嚴重的擔憂，因此需要診斷和治療解決方案。此外，為了追求職業目標和其他生活願望而延遲生育的趨勢導致男性與年齡相關的生育問題增加。這刺激了對男性不孕症治療和輔助生殖技術的需求。除此之外，由於教育活動和數位資源，人們對生育問題的認知不斷提高，促使更多男性因不孕症而尋求醫療援助，從而推動了市場的成長。除此之外，久坐的生活方式、不良的飲食習慣以及接觸環境毒素的增加也與精子品質和數量下降有關。隨著人們越來越意識到這些因素，對抵消這些影響的干涉和治療的需求也隨之增加。與此一致的是，醫療技術的進步提高了男性不孕症診斷程序和治療方案的準確性。精子 DNA 碎片分析和先進的精子選擇方法等創新技術提高了治療效果。

男性不孕症市場趨勢/促進因素：

男性不孕症盛行率不斷增加

久坐的生活方式、接觸環境污染物和高壓力等多種因素共同導致了男性生育問題的增加。這些因素會對精子的產生、品質和活力產生不利影響。隨著男性不孕症的盛行率得到越來越多的認知，對準確診斷和有效治療方案的需求不斷成長。夫婦們正在尋求醫療專業知識來解決這些問題，從而導致諮詢和生育服務的採用增加。

晚育趨勢上升

由於社會規範和職業抱負的不斷變化，推遲生育的趨勢已愈演愈烈。然而，年齡成長與男性生育能力下降有關，包括精子品質下降和 DNA 碎片增加。這種現象為男性帶來了與年齡相關的生育挑戰。因此，男性不孕症市場見證了希望在晚年組建家庭的老年男性對保留生育能力和治療選擇的需求激增。這一趨勢強調需要專門的干涉措施來滿足這一人群的獨特需求。

重大技術進步

精子 DNA 碎片分析等創新技術可以更全面地評估精子品質。此外，先進的精子選擇方法，例如磁激活細胞分選（MACS），可以提高成功受精的機會。這些技術提高了識別不孕症根本原因的準確性，並為醫療保健專業人員提供了更廣泛的工具來客製化治療計劃。隨著技術的不斷發展，它有可能透過為患者提供更有效和個人化的解決方案來顯著改善結果並促進男性不孕症市場的成長。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球男性不孕症市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按測試類型

  • 精子凝集
    • 市場走向
    • 市場預測
  • DNA斷裂技術
    • 市場走向
    • 市場預測
  • 氧化壓力分析
    • 市場走向
    • 市場預測
  • 電腦輔助精液分析
    • 市場走向
    • 市場預測
  • 精子穿透試驗
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按處理方式

  • 藥物
    • 市場走向
    • 市場預測
  • 輔助生殖技術和精索靜脈曲張手術
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 藥局和藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 生育中心
    • 市場走向
    • 市場預測
  • 研究機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Andrology Solutions
    • CinnaGen Co.
    • Halotech DNA
    • SCSA Diagnostics Inc.
    • Vitrolife
    • Zydus Lifesciences Limited
    • Intas Pharmaceuticals Ltd.
    • Endo International plc
Product Code: SR112024A6416

The global male infertility market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.79% during 2024-2032. The increasing prevalence of male infertility, rising trend of delayed parenthood, significant technological advancements, evolving lifestyles, increasing awareness about infertility, and legalization of assisted reproductive technologies are some of the major factors propelling the market.

Male infertility refers to the condition in which a man is unable to impregnate a female partner due to factors related to his reproductive system. It is often attributed to issues with sperm production, quality, or delivery. Factors that can contribute to male infertility include low sperm count, abnormal sperm shape or motility, hormonal imbalances, genetic factors, and certain medical conditions like varicocele (enlarged veins in the scrotum). Lifestyle factors such as excessive alcohol consumption, smoking, drug use, and obesity can also play a role in male infertility.

The rising incidence of male infertility worldwide is a significant driver for the market. Changing lifestyles, environmental pollutants, and stress-related factors contribute to this growing concern, necessitating the need for diagnostic and treatment solutions. Additionally, the trend of delaying parenthood to pursue career goals and other life aspirations has led to higher age-related fertility issues among men. This has spurred the demand for male infertility treatments and assisted reproductive technologies. Other than this, increasing awareness about fertility issues, thanks to educational campaigns and digital resources, has prompted more men to seek medical assistance for infertility problems, thus driving the market growth. Besides this, sedentary lifestyles, poor dietary habits, and increased exposure to environmental toxins have been linked to declining sperm quality and quantity. As individuals become more conscious of these factors, the demand for interventions and treatments to counteract these effects has risen. In line with this, advancements in medical technologies have improved the accuracy of diagnostic procedures and treatment options for male infertility. Innovative techniques such as sperm DNA fragmentation analysis and advanced sperm selection methods have enhanced treatment outcomes.

Male Infertility Market Trends/Drivers:

Increasing Prevalence of Male Infertility

A multitude of factors, including sedentary lifestyles, exposure to environmental pollutants, and high stress levels, have collectively contributed to a rise in fertility issues among men. These factors can adversely affect sperm production, quality, and motility. As the prevalence of male infertility becomes more recognized, there is a growing demand for accurate diagnostics and effective treatment options. Couples are seeking medical expertise to address these concerns, leading to increased consultations and adoption of fertility services.

Rising Trend of Delayed Parenthood

The trend of delaying parenthood has gained momentum due to evolving societal norms and career aspirations. However, advancing age is associated with a decline in male fertility, including decreased sperm quality and increased DNA fragmentation. This phenomenon has given rise to age-related fertility challenges among men. As a result, the male infertility market is witnessing a surge in demand for fertility preservation and treatment options among older men who wish to start families later in life. This trend emphasizes the need for specialized interventions that cater to the unique requirements of this demographic.

Significant Technological Advancements

Innovative techniques such as sperm DNA fragmentation analysis enable a more comprehensive assessment of sperm quality. Additionally, advanced sperm selection methods, such as magnetic-activated cell sorting (MACS), enhance the chances of successful fertilization. These technologies offer improved accuracy in identifying underlying causes of infertility and provide healthcare professionals with a wider range of tools to tailor treatment plans. As technology continues to evolve, it has the potential to significantly improve outcomes and contribute to the growth of the male infertility market by providing patients with more effective and personalized solutions.

Male Infertility Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global male infertility market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on test type, treatment, distribution channel and end user.

Breakup by Test Type:

Sperm Agglutination

DNA Fragmentation Technique

Oxidative Stress Analysis

Computer Assisted Semen Analysis

Sperm Penetration Assay

Others

DNA fragmentation technique dominates the market

The report has provided a detailed breakup and analysis of the market based on the test type. This includes sperm agglutination, DNA fragmentation technique, oxidative stress analysis, computer assisted semen analysis, sperm penetration assay, and others. According to the report, DNA fragmentation technique represented the largest segment.

The DNA fragmentation technique stands as the largest segment in the market breakup by test type due to its ability to offer deeper insights into male infertility. This technique assesses DNA damage within sperm, providing crucial information about sperm quality. As a result, it has gained prominence in accurately diagnosing the underlying causes of male infertility, guiding tailored treatment approaches for better outcomes.

Breakup by Treatment:

Medication

Assisted Reproductive Technology and Varicocele Surgery

Assisted reproductive technology and varicocele surgery hold the largest market share

A detailed breakup and analysis of the market based on the treatment has also been provided in the report. This includes medication and assisted reproductive technology and varicocele surgery. According to the report, assisted reproductive technology and varicocele surgery accounted for the largest market share.

ART, encompassing techniques like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), offers couples the opportunity to overcome various fertility challenges, including male factor infertility. The success rates and advancements in ART have positioned it as a leading choice. Varicocele surgery, on the other hand, is a well-established surgical intervention to treat varicoceles, which are dilated veins in the scrotum that can impede sperm production and quality. By surgically correcting varicoceles, blood flow is improved, potentially enhancing sperm production and motility. This procedure has demonstrated positive outcomes in restoring fertility potential. The popularity of these treatments arises from their proven efficacy, leading to their prominent status in the market's treatment landscape.

Breakup by Distribution Channel:

Hospitals Pharmacies

Pharmacies and Drug Stores

Online Pharmacies

Male infertility products are majorly distributed through hospital pharmacies

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospitals pharmacies, pharmacies and drug stores, and online pharmacies. According to the report, hospitals pharmacies represented the largest segment.

Hospitals offer a range of specialized diagnostic facilities, medical expertise, and treatment options under one roof. This makes them a primary destination for patients seeking comprehensive evaluation, consultations with fertility specialists, and advanced interventions, including assisted reproductive technologies (ART) and surgical procedures. Pharmacies play a crucial role by providing access to prescription medications, supplements, and fertility-related products that support male reproductive health. They serve as convenient points of access for patients to obtain prescribed medications for fertility treatment and management. Additionally, pharmacies offer a discreet environment where individuals can access over-the-counter fertility supplements and products that complement treatment plans.

Breakup by End User:

Hospitals and Clinics

Fertility Centers

Research Institutes

Others

Fertility centers account for the majority of the share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals and clinics, fertility centers, research institutes, and others. According to the report, fertility centers accounted for the largest market share.

These centers are dedicated to providing a wide range of services specifically tailored to individuals and couples facing fertility challenges. Fertility centers house a team of experienced reproductive endocrinologists, urologists, embryologists, and other specialists who collectively offer advanced diagnostic evaluations, personalized treatment plans, and assisted reproductive technologies (ART) under one roof. The multidisciplinary nature of fertility centers allows for a holistic approach to male infertility, encompassing medical assessments, laboratory analyses, and innovative treatments. These centers offer a supportive environment that addresses the emotional and physical aspects of fertility struggles. The availability of state-of-the-art technologies, cutting-edge procedures, and a comprehensive understanding of male reproductive health positions fertility centers as the preferred choice for individuals seeking expert guidance and successful outcomes in their journey towards overcoming male infertility.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Europe exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest market share.

The region possesses a well-developed healthcare infrastructure, including advanced medical facilities, fertility clinics, and research institutions, enabling efficient diagnosis and treatment of male infertility. Moreover, changing socio-cultural dynamics have led to increased awareness and acceptance of fertility issues, prompting more individuals and couples to seek medical intervention. European countries also prioritize reproductive health and offer comprehensive healthcare coverage, making fertility treatments more accessible to a larger population. The aging population across the region contributes to a growing demand for assisted reproductive technologies (ART) as delayed parenthood becomes more common. Furthermore, the strong presence of Europe in medical research and development fuels innovations in male infertility treatments, attracting both domestic and international patients seeking cutting-edge solutions.

Competitive Landscape:

Leading companies are investing significantly in research and development to create new and improved diagnostic tools, treatments, and technologies for male infertility. This includes developing innovative sperm analysis techniques, medications, and assisted reproductive technologies to enhance treatment outcomes. Additionally, key players often collaborate with academic institutions, research organizations, and healthcare providers to exchange knowledge, share insights, and drive advancements in male infertility diagnostics and treatments. These collaborations foster a synergistic approach to tackling complex challenges and developing comprehensive solutions. Other than this, recognizing the importance of raising awareness about male infertility, industry leaders are actively involved in educational initiatives. They offer information through online platforms, seminars, and healthcare professional training, aimed at increasing understanding of the condition and encouraging timely interventions. Moreover, key players engage in strategic expansion efforts to tap into emerging markets with growing demand for male infertility treatments. By extending their reach, they aim to provide access to advanced diagnostics and therapies to a wider patient population.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Andrology Solutions

CinnaGen Co.

Halotech DNA

SCSA Diagnostics Inc.

Vitrolife

Zydus Lifesciences Limited

Intas Pharmaceuticals Ltd.

Endo International plc.

Recent Developments:

Andrology Solutions has made recent advancements in the field of male infertility, including improvements in the understanding and management of male factor infertility. It has also worked on developing panels for male infertility genes, which have achieved high accuracy in diagnosing copy number variants (CNVs). These advancements contribute to the diagnosis and treatment of male infertility, allowing for more effective interventions and improved outcomes.

Halotech DNA, a leading international biotech company based in Madrid, has introduced innovative DNA fragmentation analysis systems for evaluating sperm quality. These systems are designed to assess the level of DNA damage in sperm cells, which can be a contributing factor to male infertility. This analysis helps in identifying the underlying causes of infertility and guides the selection of appropriate treatment options.

In 2022, SCSA Diagnostics Inc. developed a test called the SCSA (Sperm Chromatin Structure Assay), which is used to evaluate sperm chromatin structure and DNA strand breaks. The SCSA test is a two-fold simultaneous flow cytometry measure of the extent of sperm nuclear single (ss) and double (ds) strand DNA breaks. This test provides unique information about male infertility by assessing the integrity of sperm DNA, which is crucial for successful fertilization and embryo development.

Key Questions Answered in This Report

  • 1. What was the size of the global male infertility market in 2023?
  • 2. What is the expected growth rate of the global male infertility market during 2024-2032?
  • 3. What are the key factors driving the global male infertility market?
  • 4. What has been the impact of COVID-19 on the global male infertility market?
  • 5. What is the breakup of the global male infertility market based on the test type?
  • 6. What is the breakup of the global male infertility market based on the treatment?
  • 7. What is the breakup of the global male infertility market based on the distribution channel?
  • 8. What is the breakup of the global male infertility market based on the end user?
  • 9. What are the key regions in the global male infertility market?
  • 10. Who are the key players/companies in the global male infertility market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Male Infertility Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Sperm Agglutination
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DNA Fragmentation Technique
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidative Stress Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Computer Assisted Semen Analysis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Sperm Penetration Assay
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Treatment

  • 7.1 Medication
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Assisted Reproductive Technology and Varicocele Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Fertility Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Andrology Solutions
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 CinnaGen Co.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Halotech DNA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 SCSA Diagnostics Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Vitrolife
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Zydus Lifesciences Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Intas Pharmaceuticals Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Endo International plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Male Infertility Market: Major Drivers and Challenges
  • Figure 2: Global: Male Infertility Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Male Infertility Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Male Infertility Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Male Infertility Market: Breakup by Treatment (in %), 2023
  • Figure 6: Global: Male Infertility Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Male Infertility Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Male Infertility Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Male Infertility (Sperm Agglutination) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Male Infertility (Sperm Agglutination) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Male Infertility (DNA Fragmentation Technique) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Male Infertility (DNA Fragmentation Technique) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Male Infertility (Oxidative Stress Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Male Infertility (Oxidative Stress Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Male Infertility (Computer Assisted Semen Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Male Infertility (Computer Assisted Semen Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Male Infertility (Sperm Penetration Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Male Infertility (Sperm Penetration Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Male Infertility (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Male Infertility (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Male Infertility (Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Male Infertility (Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Male Infertility (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Male Infertility (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Male Infertility (Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Male Infertility (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Male Infertility (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Male Infertility (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Male Infertility (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Male Infertility (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Male Infertility (Fertility Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Male Infertility (Fertility Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Male Infertility (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Male Infertility (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Male Infertility (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Male Infertility (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Male Infertility Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Male Infertility Industry: SWOT Analysis
  • Figure 89: Global: Male Infertility Industry: Value Chain Analysis
  • Figure 90: Global: Male Infertility Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Male Infertility Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Male Infertility Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Male Infertility Market Forecast: Breakup by Treatment (in Million US$), 2024-2032
  • Table 4: Global: Male Infertility Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Male Infertility Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Male Infertility Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Male Infertility Market: Competitive Structure
  • Table 8: Global: Male Infertility Market: Key Players